Principal Investigator
Antonio Jimenez
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230190
Clinical Trial Summary
A Phase 1 Study of Venetoclax in Combination with Azacitidine (VEN/AZA) followed by Donor Lymphocyte Infusion (DLI) for Patients with Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Phase
Phase I
Funding Agency/Sponsor
Institutional
Disease
Leukemia/heme
Contact Information
Phone Number
305-243-2647